The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.
 
Athanassios Argiris
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Merck Serono
Research Funding - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Yael Flamand
No Relationships to Disclose
 
Panayiotis Savvides
No Relationships to Disclose
 
Jennifer Maria Johnson
Consulting or Advisory Role - Bistol-Myers Squibb; Foundation Medicine; Rakuten Medical
Research Funding - AstraZeneca; Bristol-Myers Squibb; Merck
(OPTIONAL) Uncompensated Relationships - Taproot Health Inc
 
Shuli Li
Employment - Takeda
Stock and Other Ownership Interests - Takeda
 
Arlene A. Forastiere
Consulting or Advisory Role - United Health Group
 
Barbara Burtness
Consulting or Advisory Role - ALX Oncology; CUE Biopharma; Debiopharm Group; Exelixis; Genentech/Roche; IO Biotech; Ipsen; Kura Oncology; Macrogenics; Maverick Therapeutics; Merck; Merck KGaA; Nanobiotix; PPD Global; Rakuten Medical
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - AstraZeneca; CUE Biopharma (Inst); Eisai; Exelixis (Inst); Genentech; Kura Oncology; Merck; Merck (Inst); Nektar; Rakuten Medical
Travel, Accommodations, Expenses - Debiopharm Group; Merck